Structure-activity relationship of inositol thiophosphate analogs as allosteric activators of Clostridioides difficile toxin B

21 June 2024, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Clostridioides difficile is a bacterium that causes life-threatening intestinal infections. Infection symptoms are mediated by a toxin secreted by the bacterium. Toxin pathogenesis is modulated by the intracellular molecule, inositol-hexakisphosphate (IP6). IP6 binds to a cysteine protease domain (CPD) on the toxin, inducing auto-proteolysis, which liberates a virulence factor in the cell cytosol. We developed second-generation IP6 analogs designed to induce auto-proteolysis in the gut lumen, prior to toxin uptake, circumventing pathogenesis. We synthesized a panel of thiophosphate-/sulfate-containing IP6 analogs, and characterized their toxin binding affinity, auto-proteolysis induction and cation interactions. Our top candidate was soluble in extracellular cation concentrations, unlike IP6. The IP6 analogs were more negatively charged than IP6, which improved affinity and stabilization of the CPD, enhancing toxin auto-proteolysis. Our data illustrate the optimization of IP6 with thiophosphate biomimetics which are more capable of inducing toxin auto-proteolysis than the native ligand, warranting further studies in vivo.

Keywords

Clostridioides difficile
inositol
bacterial toxins
TcdB

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Additional figures containing the colorimetric assay standard curve, ITC raw datasets, extent cleavage data for IP5Bn, pK determination raw datasets, supplementary 1H-15N HSQC results, 31P NMR reaction tracking of the HSQC experiment, all silver-stained gels and western blot membranes, and all NMR’s of the characterized compounds.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.